| Names | |
|---|---|
| Preferred IUPAC name
4-Amino-N-ethyl-N,N-dimethyl-4-oxo-3,3-diphenylbutan-1-aminium bromide | |
| Identifiers | |
| |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.003.721 |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| Properties | |
| C20H27BrN2O | |
| Molar mass | 391.35 g/mol |
| Pharmacology | |
| A03CA07 (WHO) in combination with | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Ambutonium bromide is a muscarinic antagonist used in ulcer therapy1
References
References
- Schwartz, I. R.; Lehman, E.; Seibel, J. M. (1960). "The effect of ambutonium bromide, a new anticholinergic agent in ulcer therapy". The American Journal of Gastroenterology. 33: 704–717. ISSN 0002-9270. PMID 14443986..
